Aspen $JSEAPN - It maybe worth parking some spare change in the pharma name, if only because it has positive delta to Covid unlike other stocks. It's climbing quietly. Fundamentally any cashflow boost will be a catalyst, that helps its beleaguered balance sheet BUY #JSE #stocks https://t.co/h0GGncpLXM